2022, doi: 10.1001/jamainternmed.2022.3810
- : Rapid growth in obesity & metabolic therapies Expansion of immunotherapy and precision oncology Increasing demand for biologics and specialty drugs Strong innovation in chronic disease management Rising global healthcare spending and drug accessibility Leading pharmaceutical innovators including Merck & Co., AbbVie, Bristol Myers Squibb, Pfizer, and Gilead Sciences continue to shape the future of global medicine through high-impact therapies and continuous R&D investment
Shi S, Shuang S, Xiangdong L, Guoqiang Z, Feng D, Wenshuang Z, et al
Funding rounds and Biotech IPOs: Venture capital and the public markets have invested capital in weight-loss Biotech
Which GLP-1 Medications are most likely to cause diarrhea
HIGHLIGHTS OF PRESCRIBING INFORMATION [Internet]